{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:44:26Z","timestamp":1778625866855,"version":"3.51.4"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,8,15]]},"DOI":"10.2169\/internalmedicine.4431-20","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T22:08:46Z","timestamp":1590185326000},"page":"2053-2059","source":"Crossref","is-referenced-by-count":7,"title":["Progressive Multifocal Leukoencephalopathy during Tocilizumab Treatment for Rheumatoid Arthritis"],"prefix":"10.2169","volume":"59","author":[{"given":"Mamiko","family":"Anada","sequence":"first","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyoka","family":"Tohyama","sequence":"additional","affiliation":[{"name":"Miyoka Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuta","family":"Kamoshima","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sapporo Azabu Neurosurgical Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Amino","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihito","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusei","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Akimoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Terae","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Sapporo City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Niino","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Iacobaeus E, Burkill S, Bahmanyar S, et al. The national incidence of PML in Sweden, 1988-2013. Neurology 90: e498-e506, 2018.","DOI":"10.1212\/WNL.0000000000004926"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Clavel G, Moulignier A, Semerano L. Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments. Joint Bone Spine 84: 671-675, 2017.","DOI":"10.1016\/j.jbspin.2017.03.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sheppard M, Laskou F, Stapleton PP, Hadavi S, Dasgupta B. Tocilizumab (Actemra). Hum Vaccin Immunother 13: 1972-1988, 2017.","DOI":"10.1080\/21645515.2017.1316909"},{"key":"4","unstructured":"4. Japanese guideline for progressive multifocal leukoencephalopathy 2017 [Internet]. Available from: http:\/\/prion.umin.jp\/guideline\/guideline_PML_2017.pdf (in Japanese)."},{"key":"5","unstructured":"5. Maas RP, Muller-Hansma AH, Esselink RA, et al. Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases. J Neurol 263: 2004-2021, 2016."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cheng CF, Su JJ, Chen YF, Lin YC, Huang YM, Li KJ. Progressive multifocal leukoencephalopathy in a 27-year-old lady with systemic lupus erythematosus - rheumatoid arthritis overlap syndrome. J Formos Med Assoc 118: 1560-1565, 2019.","DOI":"10.1016\/j.jfma.2019.05.021"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nishigori R, Warabi Y, Shishido-Hara Y, et al. Inflammatory cerebellar PML with a CD4\/CD8 ratio of 2.9 showed a favorable prognosis in a patient with rheumatoid arthritis. Intern Med 58: 3323-3329, 2019.","DOI":"10.2169\/internalmedicine.3038-19"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. de Regt MJ, Murk JL, Schneider-Hohendorf T, Wattjes MP, Hoepelman AI, Arends JE. Progressive multifocal leukoencephalopathy and black fungus in a patient with rheumatoid arthritis without severe lymphocytopenia. JMM Case Rep 3: e005053, 2016.","DOI":"10.1099\/jmmcr.0.005053"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Lach B, Connolly B, W\u00fcthrich C, Koralnik IJ. Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis. Neuropathology 34: 39-44, 2014.","DOI":"10.1111\/neup.12045"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rath T, Hackenbroch M, Saech J, Hallek M, Rubbert A. Longterm remission of more than 5 years in a patient with progressive multifocal leucoencephalopathy and sarcoidosis. Clin Neurol Neurosurg 114: 1057-1058, 2012.","DOI":"10.1016\/j.clineuro.2012.02.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kumar D, Bouldin TW, Berger RG. A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab. Arthritis Rheum 62: 3191-3195, 2010.","DOI":"10.1002\/art.27687"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Marzocchetti A, Wuthrich C, Tan CS, et al. Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirol 14: 455-458, 2008.","DOI":"10.1080\/13550280802356837"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shprecher D, Frech T, Chin S, Eskandari R, Steffens J. Progressive multifocal leucoencephalopathy associated with lupus and methotrexate overdose. Lupus 17: 1029-1032, 2008.","DOI":"10.1177\/0961203308089435"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nosaki Y, Ohyama K, Watanabe M, et al. Simultaneous development of progressive multifocal leukoencephalopathy and cryptococcal meningitis during methotrexate and infliximab treatment. Intern Med 58: 2703-2709, 2019.","DOI":"10.2169\/internalmedicine.2570-18"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sammut L, Wallis D, Holroyd C. Progressive multifocal leukoencephalopathy associated with infliximab. J R Coll Physicians Edinb 46: 163-165, 2016.","DOI":"10.4997\/JRCPE.2016.305"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gosert R, Kardas P, Major EO, Hirsch HH. Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate. J Virol 84: 10448-10456, 2010.","DOI":"10.1128\/JVI.00614-10"},{"key":"17","unstructured":"17. Bohra C, Sokol L, Dalia S. Progressive multifocal leukoencephalopathy and monoclonal antibodies: a review. cancer control 24: 1073274817729901, 2017."},{"key":"18","unstructured":"18. Spencer S, K\u00f6stel Bal S, Egner W, et al. Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses. J Exp Med 216: 1986-1998, 2019."},{"key":"19","unstructured":"19. Shimada H, Dobashi H, Morimoto H, et al. Primary central nervous system lymphoma in a rheumatoid arthritis patient treated with methotrexate: a case report. BMC Res Notes 8: 88, 2015."},{"key":"20","unstructured":"20. Liu W, Xue J, Yu S, Chen Q, Li X, Yu R. Primary central nervous system lymphoma mimicking recurrent depressive disorder: a case report. Oncol Lett 9: 1819-1821, 2015."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Uchida Y, Hokkoku K, Hatanaka Y, Kikuchi Y, Tashiro H, Sonoo M. Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis. Rinsho Shinkeigaku (Clin Neurol) 58: 485-491, 2018 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.cn-001157"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sanjo N, Kina S, Shishido-Hara Y, et al. Progressive multifocal leukoencephalopathy with balanced CD4\/CD8 T-Cell infiltration and good response to Mefloquine treatment. Intern Med 55: 1631-1635, 2016.","DOI":"10.2169\/internalmedicine.55.6051"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Beppu M, Kawamoto M, Nukuzuma S, Kohara N. Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Intern Med 51: 1245-1247, 2012.","DOI":"10.2169\/internalmedicine.51.6810"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Brickelmaier M, Lugovskoy A, Kartikeyan R, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53: 1840-1849, 2009.","DOI":"10.1128\/AAC.01614-08"},{"key":"25","unstructured":"25. Aoyama S, Mori M, Uzawa A, et al. Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration. J Neurol 265: 1145-1150, 2018."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/16\/59_4431-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T03:19:55Z","timestamp":1597461595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/16\/59_4431-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,15]]},"references-count":25,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4431-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,15]]}}}